Immunotherapy with DNA vaccine shows promise for HPV-related head and neck cancer

Via Top Health News -- ScienceDaily

A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers. The treatment specifically targets human papillomavirus (HPV), which is frequently associated with HNSCCa, to trigger the immune response.

View original post here:

%d bloggers like this: